Literature DB >> 35674876

Anticancer effects of marine compounds blocking the nuclear factor kappa B signaling pathway.

Jiaen Wei1, Yaqi Liu1, Fei Teng1, Linshan Li1, Shanhong Zhong1, Hui Luo2, Zunnan Huang3,4.   

Abstract

The abnormal expression of nuclear factor kappa B (NF-κB) target genes is closely related to the occurrence, metastasis, and invasion of tumor cells and is an inhibitor of their apoptosis. In recent years, the unique biodiversity in the marine environment has aroused great interest. Many studies indicate that some marine compounds exert anticancer effects on most common human tumors by modulating the NF-κB signaling pathway. In this study, 26 marine compounds that reduce cancer cell survival by suppressing the NF-κB signaling pathway were reviewed. They were derived from a wide range of sources, including sponges, fungi, algae and their derivatives or metabolites. These marine compounds exert antitumor effects through the canonical, noncanonical and atypical NF-κB signaling pathways; however, most of their anticancer targets and mechanisms remain unclear, and more research is needed in the future. Our article provides comprehensive information for researchers investigating the bioactivities of marine compounds and developing marine-derived anticancer drugs.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Anticancer; Canonical; Marine compounds; Noncanonical and atypical pathways of NF-κB signaling

Mesh:

Substances:

Year:  2022        PMID: 35674876     DOI: 10.1007/s11033-022-07556-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  59 in total

Review 1.  Marine organisms and other novel natural sources of new cancer drugs.

Authors:  G Schwartsmann
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

Review 2.  Marine natural products and related compounds in clinical and advanced preclinical trials.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2004-08       Impact factor: 4.050

Review 3.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

Review 4.  NF-κB and the link between inflammation and cancer.

Authors:  Joseph A DiDonato; Frank Mercurio; Michael Karin
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

5.  The aromatic ketone 4'-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition.

Authors:  Barbora Orlikova; Deniz Tasdemir; Frantisek Golais; Mario Dicato; Marc Diederich
Journal:  Biochem Pharmacol       Date:  2011-06-14       Impact factor: 5.858

Review 6.  Cancer Incidence and Trends.

Authors:  Melissa C Hulvat
Journal:  Surg Clin North Am       Date:  2020-03-27       Impact factor: 2.741

7.  Marine steroids as potential anticancer drug candidates: In silico investigation in search of inhibitors of Bcl-2 and CDK-4/Cyclin D1.

Authors:  Surovi Saikia; Bhaskor Kolita; Partha P Dutta; Deep J Dutta; Shyamalendu Nath; Manobjyoti Bordoloi; Pham Minh Quan; Tran Thu Thuy; Doan Lan Phuong; Pham Quoc Long
Journal:  Steroids       Date:  2015-06-22       Impact factor: 2.668

Review 8.  NF-kB in development and progression of human cancer.

Authors:  Xavier Dolcet; David Llobet; Judit Pallares; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2005-04-27       Impact factor: 4.064

Review 9.  Anticancer activity of seaweeds.

Authors:  Anllely G Gutiérrez-Rodríguez; Claudia Juárez-Portilla; Tatiana Olivares-Bañuelos; Rossana C Zepeda
Journal:  Drug Discov Today       Date:  2017-10-26       Impact factor: 7.851

Review 10.  Mechanisms of NF-κB p65 and strategies for therapeutic manipulation.

Authors:  Sivagami Giridharan; Mythily Srinivasan
Journal:  J Inflamm Res       Date:  2018-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.